Organization: BioMS Medical Corp

BioMS Medical strikes major deal with Eli Lilly

Edmonton-based BioMS Medical Corp has struck a major licensing and development agreement with Eli Lilly and Co, Indianapolis IN to develop its multiple sclerosis compound. The deal — one of the largest in Canadian history for a single compound — calls for an $87-million upfront payment, development and sales milestone payments of up to $410…